Founded in St. Gallen, Switzerland, the Home of Iron is rooted in a legacy spanning more than a century. Since 1949, this site has been central to CSL Vifor’s manufacturing capabilities, earning its title as the ‘Home of Iron’ through decades of precision, quality, and innovation deeply rooted in Swiss craftsmanship.
More than a manufacturing hub, it’s deeply connected to the St. Gallen community, partnering with local businesses, research centres, and educational institutions to uphold its legacy as a regional centre of pharmaceutical excellence and collaboration.
Experience the Home of Iron like never before
Take a look around our St. Gallen site to better understand our legacy and operations. The virtual tour lets you peek behind the curtain of the Home of Iron, giving you a glimpse into our innovative design and daily operations.
Built on a rich heritage
This moment marked the beginning of a legacy. Driven by a deep commitment to addressing iron deficiency, Hausmann’s early innovations laid the groundwork for what would become over a century of progress in iron therapy. His vision and scientific curiosity continue to inspire our work today.
The foundation of Vifor Ltd. in Switzerland marked a pivotal step in our evolution. Initially focused on hospital supplies, the company quickly built a reputation for reliability and quality – principles that remain at the heart of everything we do. This era set the stage for future breakthroughs in pharmaceutical care.
With the formation of Laboratories Hausmann Ltd., our dedication to iron therapy deepened. This milestone represented a commitment to scientific rigour, enabling focused research and development that would elevate standards in patient treatment spanning generations.
The acquisition of Vifor Ltd. by Galenica marked a new chapter of growth. It brought fresh energy, broader capabilities, and a renewed focus on addressing unmet medical needs – laying the foundation for a dynamic, integrated pharmaceutical group.
Bringing Laboratories Hausmann into the Galenica family united two pioneers under one vision. Together, they formed a stronger force in iron therapy, blending deep scientific expertise with a growing ambition to serve patients more holistically.
The creation of Vifor (International) AG reflected a growing global ambition. As we reached beyond borders, we remained grounded in Swiss quality and innovation, sharing our expertise worldwide while staying true to our roots in precision and care.
The launch of VFMCRP represented a deepened focus on patients with chronic kidney disease. This strategic partnership combined strengths to develop and deliver solutions for some of the most pressing challenges in renal care – always with the patient at the centre.
Becoming an independent, publicly listed company was a defining moment. It gave Vifor Pharma the autonomy to forge its own path, accelerate innovation, and grow with purpose, all while honouring the legacy that brought us here.
Our acquisition of Sanifit Therapeutics and Inositec signalled a bold step into new areas of innovation. These additions strengthened our position in cardio-renal care and rare diseases, expanding the scope of our mission to improve lives through science.
“Together we are stronger, with complementary capabilities that enhance our global therapeutic positions, capacity for innovation, scale and growth potential,” CSL CEO and Managing Director Paul Perreault said of the acquisition finalized on August 9.
For patients in Europe and around the world
We’ve been discovering, developing, and producing iron solutions for more than 70 years in St. Gallen, Switzerland – our Home of Iron.